Feb 4 (Reuters) - Sienna Cancer Diagnostics Ltd (SDX) : MEDIWELL ENTERPRISE PTE APPOINTED AS DISTRIBUTION PARTNER FOR SINGAPORE AGREEMENT ALLOWS MEDIWELL RIGHT TO SELL SIENNA'S IN-VITRO DIAGNOSTIC HTERT TEST TO PATHOLOGY LABS AND HOSPITALS
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
